StockGlow

Repligen Corporation (RGN.F)

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

123.85+0.02%Healthcare
Compare RGN.F with
StockGlow Score
75
Leaning Bullish
BearishBullish
1 year ago+23.6%

The outlook

Repligen Corporation currently reads as leaning bullish based on above its 50- & 200-day averages, 62% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range62% of the way from its 52-week low to high
Market cap
$6.99B
52-wk high
147.10
52-wk low
86.32
50-day avg
114.85
200-day avg
118.43
Trailing P/E
154.8

Similar stocks

B1F.FBuilders FirstSource, Inc.$57.38-2.32%RV7.FHalozyme Therapeutics, Inc.$72.16-0.39%EAC.FEastman Chemical Company$60.08+1.62%BKD.FBruker Corporation$55.83+4.12%I5M.FIron Mountain Incorporated$108.35+2.85%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy